Back to JANE STREET GROUP, LLC JANE STREET GROUP, LLC

CRDFCRDF
Showing 7 of 16 quarters

Position history for JANE STREET GROUP, LLCJANE STREET GROUP, LLC's holdings in CARDIFF ONCOLOGY INC

JANE STREET GROUP, LLC holds 607,900 shares of CRDF (CARDIFF ONCOLOGY INC), worth $790,270 as of 2026-Q2. The position was increased (+1415.8% shares). CRDF represents 0.0% of JANE STREET GROUP, LLC's portfolio.

Current Value

$790,270

Current Shares

607,900

Total Value Change

+$672,795

Total Shares Change

+563,902

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
607,900
+1415.8%
$790,2700.0%$1.30
40
2026-Q1
Decreased
40,105
-69.8%
$64,9700.0%$1.89
0
2025-Q4
Decreased
132,850
-18.0%
$373,3080.0%$2.87
0
2025-Q3
New
161,928
-
$333,5720.0%$2.08
33
2025-Q1
Exited
0
-100.0%
$00.0%$3.29
0
2024-Q4
Decreased
21,608
-50.9%
$93,7790.0%$4.26
0
2024-Q3
Decreased
43,998
-54.6%
$117,4750.0%$2.77
0

Other major holders of CRDF: RA CAPITAL MANAGEMENT, L.P., Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used